Oncostatin M is a novel biomarker for coronary artery disease – A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus

OBJECTIVE: Oncostatin M (OSM) is an inflammatory cytokine of the interleukin-6 family which plays a crucial role in the pathogenesis of atherosclerosis. Therefore, we tested our hypothesis that serum OSM levels are increased in patients with coronary artery diseases (CAD). METHODS AND RESULTS: Serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Shohei, Sato, Koichi, Takeda, Morihiko, Miki, Keita, Aizawa, Kentaro, Takada, Tsuyoshi, Fukuda, Koji, Shiba, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250159/
https://www.ncbi.nlm.nih.gov/pubmed/34235245
http://dx.doi.org/10.1016/j.ijcha.2021.100829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250159/
https://www.ncbi.nlm.nih.gov/pubmed/34235245
http://dx.doi.org/10.1016/j.ijcha.2021.100829

Ejemplares similares